MedTrace Logo

Decision Impact Study to Measure the Influence of DECIPHER on Treatment Recommendations

NCT02020876 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 21

Last updated 2013-12-25

No results posted yet for this study

Summary

This clinical utility study pilot is based on a review of real but de-identified and randomized patient cases and aims to evaluate Urologists' treatment recommendations before and after reviewing the results provided by the Decipher test. This is a pilot study and the primary intent is to help guide development and design of future clinical utility studies for Decipher

Conditions

Interventions

OTHER

DECIPHER Questionnaire

Participants are asked to complete a questionnaire to assess the impact of Decipher on physicians' treatment recommendation. All participants use the same data collection instrument. Each participant opinion is collected based on a random selection of cases.

Sponsors & Collaborators

  • GenomeDx Biosciences Corp

    lead INDUSTRY

Principal Investigators

  • Elai Davicioni, pHd · GenomeDx Biosciences Inc.

  • Badani Ketan, MD · Department of Urology, Columbia University, New York, NY USA

Eligibility

Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-08-31
Primary Completion
2013-01-31
Completion
2013-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02020876 on ClinicalTrials.gov